ClinicalTrials.gg
CompletedNCT07877181Updated Oct 20, 2026

Vibrating and Non-Vibrating Foam-Rolling on DOMS

An interventional study of Vibrating Foam Rolling and Non-Vibrating Foam Rolling in Delayed Onset Muscle Soreness (DOMS), sponsored by Hacettepe University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Hacettepe University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 3 years 9 months after the study started (first participant enrolled Jan 2023, registered Oct 2026).
Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The goal of this randomized clinical trial is to determine whether vibrating foam rolling is more effective than non-vibrating foam rolling for improving ankle function and reducing muscle soreness after delayed onset muscle soreness (DOMS) in physically active healthy adults.

The main questions this study aims to answer are:

  • Does vibrating foam rolling improve ankle dorsiflexion range of motion after DOMS?
  • Does vibrating foam rolling improve dynamic balance after DOMS?
  • Does vibrating foam rolling affect gastrocnemius muscle strength and passive muscle mechanical properties?
  • Does vibrating foam rolling reduce pain and muscle soreness after DOMS?

Researchers will compare vibrating foam rolling with non-vibrating foam rolling applied to the opposite legs of the same participants to determine whether vibration provides additional benefits.

Participants will be physically active healthy adults. The study consists of two sessions separated by 48 hours. During the first session, participants will undergo baseline assessments of muscle properties, pain, ankle range of motion, dynamic balance, and gastrocnemius muscle strength. They will then perform a weighted heel-raise exercise designed to induce delayed onset muscle soreness in the gastrocnemius muscles.

Forty-eight hours later, participants who develop sufficient muscle soreness will repeat the assessments and receive foam rolling. One leg will be randomly assigned to vibrating foam rolling and the other leg to non-vibrating foam rolling. Each leg will receive three 1-minute foam rolling sets, with 30 seconds of rest between sets. Assessments will be repeated immediately after the foam rolling intervention.

Read the detailed description

Delayed onset muscle soreness (DOMS) is a common physiological response to unaccustomed or strenuous exercise. It typically develops several hours after exercise and may become most noticeable approximately 24 to 72 hours later. DOMS can be associated with muscle soreness, changes in passive muscle mechanical properties, reduced range of motion, and temporary alterations in muscle strength and functional performance. These changes may affect movement and physical performance during the recovery period.

Foam rolling is frequently used as a recovery strategy following exercise. It is generally performed by applying body weight over a cylindrical roller and repeatedly rolling the targeted muscle region. Previous studies have reported that foam rolling may produce acute changes in flexibility, range of motion, muscle mechanical properties, perceived soreness, and physical performance. Vibrating foam rollers have additionally been developed to combine mechanical pressure with mechanical vibration. However, it is not clear whether adding vibration provides additional benefits over conventional foam rolling without vibration when these techniques are applied during the DOMS period.

The present study uses a randomized within-subject split-body design. Both lower extremities of each participant are included in the intervention. One lower extremity is randomly assigned to the vibrating foam rolling condition, while the contralateral lower extremity is assigned to the non-vibrating foam rolling condition. The assignment of the two conditions to the right and left lower extremities is determined using a computer-based randomization procedure. Because each participant receives both interventions, each participant serves as their own control. This design helps reduce the influence of individual differences in physical characteristics and baseline functional capacity when comparing the two foam rolling conditions.

The study consists of two laboratory sessions separated by 48 hours.

During the first session, baseline measurements are obtained before the DOMS-inducing exercise. The assessment includes passive mechanical properties of the medial and lateral gastrocnemius muscles, perceived pain and muscle soreness, ankle dorsiflexion range of motion, dynamic balance, and gastrocnemius muscle strength. The order and procedures of the assessments are standardized for all participants.

Passive mechanical properties of the gastrocnemius muscles are assessed using a myotonometric device. Muscle tone, stiffness, and elasticity are evaluated at standardized anatomical locations on the medial and lateral gastrocnemius. Multiple consecutive measurements are obtained from each measurement site, and the average value is used for analysis.

Perceived muscle soreness and pain are evaluated using a visual analog scale during a standardized gastrocnemius stretching procedure. Ankle dorsiflexion range of motion is assessed using the Weight-Bearing Lunge Test. Dynamic balance is evaluated using the Y-Balance Test, with each lower extremity assessed separately. Reach distances are recorded in the anterior, posteromedial, and posterolateral directions and are normalized to lower-extremity length. Gastrocnemius muscle strength is assessed isometrically using a hand-held dynamometer while the participant is positioned prone with the ankle in a standardized neutral position.

Following the baseline assessments, participants perform a standardized exercise protocol designed to induce DOMS in the gastrocnemius muscles. The protocol consists of weighted heel-raise exercises performed on a 35-degree inclined surface. Participants wear an external load corresponding to approximately 25% of their body weight. The heel-raise movement consists of a maximal concentric contraction followed by a controlled eccentric phase. A metronome is used to standardize the movement tempo. Participants perform five sets of 30 repetitions with standardized rest periods between sets, with the final set continued according to the study protocol. Participants may use overhead straps for safety and balance, while verbal instructions are provided to minimize assistance from the straps during the exercise.

Participants return to the laboratory 48 hours after the DOMS-inducing exercise. At this time point, the same functional and physiological assessments are performed before the foam rolling intervention. This assessment represents the pre-intervention DOMS state and allows the acute response to foam rolling to be evaluated relative to the condition immediately before treatment rather than only relative to the original baseline.

Participants who meet the study requirement for exercise-induced muscle soreness proceed to the foam rolling intervention. The vibrating foam rolling condition is performed using a Compex Ion vibrating foam roller, with the vibration function activated at 48 Hz. The non-vibrating condition is performed using the same foam rolling device without vibration. Both interventions consist of three 1-minute sets, with a 30-second rest period between sets.

The foam rolling application is standardized across conditions. A four-second movement cycle is used, consisting of two seconds of rolling from distal to proximal and two seconds from proximal to distal. The application area extends along the posterior lower leg from the superior aspect of the Achilles tendon to the inferior aspect of the popliteal region. Anatomical reference lines are used to standardize the application area. Participants are instructed to apply as much body weight as tolerated within their individual discomfort threshold. During each intervention, the contralateral lower extremity remains off the roller to maintain a comparable unilateral loading configuration.

Immediately after the foam rolling intervention, the assessment procedures are repeated. Changes observed after vibrating and non-vibrating foam rolling are then compared within the same participants to determine whether the addition of vibration produces different acute responses.

The study evaluates the potential effects of the two foam rolling conditions on several aspects of recovery following exercise-induced DOMS, including muscle mechanical properties, perceived soreness and pain, ankle dorsiflexion, dynamic balance, and gastrocnemius muscle strength. The findings are intended to provide information about whether vibration offers an additional acute benefit over conventional non-vibrating foam rolling during the DOMS recovery period.

The study was approved by the Hacettepe University Clinical Research Ethics Committee (KA-22073). All participants provided written informed consent before participation, and the study was conducted in accordance with the ethical principles of the Declaration of Helsinki.

02

Conditions studied

  • Delayed Onset Muscle Soreness (DOMS)

Keywords

  • Foam rolling
  • vibration therapy
  • DOMS
  • gastrocnemius
  • muscle stiffness
  • recovery
03

In context

Lead sponsor

Hacettepe University is the lead sponsor of 1,001 studies on the registry; 215 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Physically active adults with a Tegner Activity Level Scale score of 5 or 6.
  • No lower extremity injury within the previous 1 year.

Exclusion criteria

Exclusion Criteria:

  • Lower extremity injury within the previous 1 year.
  • Neurological pathology.
  • Previous surgery.
  • Body mass index (BMI) >24.9 kg/m².
  • Failure to develop delayed onset muscle soreness (DOMS), defined as a Visual Analog Scale (VAS) score \<3 following the DOMS induction protocol.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Vibrating Foam Rolling

    Other: Vibrating Foam Rolling

  • Active comparator
    Non-Vibrating Foam Rolling

    Other: Non-Vibrating Foam Rolling

Interventions

  • OtherVibrating Foam Rolling

    Vibrating foam rolling at 48 Hz, three 1-minute sets with 30-second rest intervals

  • OtherNon-Vibrating Foam Rolling

    Non-vibrating foam rolling using the same protocol and device, with vibration turned off.

06

What researchers measure

Primary outcomes

  1. Ankle Dorsiflexion Range of Motion

    Ankle dorsiflexion range of motion was assessed using the Weight-Bearing Lunge Test. Participants moved the tested knee toward the wall while maintaining heel contact. The maximum distance between the great toe and the wall was recorded in centimeters. Three measurements were performed for each lower extremity and the mean value was used for analysis.

    Time frame: Baseline, 48 hours after DOMS induction, and immediately after foam rolling

  2. Dynamic Balance

    Dynamic balance was assessed using the Y-Balance Test. Participants performed maximal reaches in the anterior, posteromedial, and posterolateral directions while maintaining single-leg stance. Each direction was measured three times and the mean reach distance was recorded. Reach distances were normalized to lower-extremity length.

    Time frame: Baseline, 48 hours after DOMS induction, and immediately after foam rolling

Secondary outcomes

  1. Gastrocnemius Muscle Strength

    Isometric gastrocnemius muscle strength was assessed using a KForce hand dynamometer. Participants were positioned prone with the knee fully extended and the ankle in a neutral position. Three measurements were obtained for each lower extremity and the mean value was used for analysis.

    Time frame: Baseline, 48 hours after DOMS induction, and immediately after foam rolling

  2. Gastrocnemius Muscle Mechanical Properties

    Passive mechanical properties of the medial and lateral gastrocnemius muscles, including muscle tone, stiffness, and elasticity, were assessed using a Myoton-3 myotonometric device. Measurements were obtained from standardized anatomical locations with the participant in the prone position, the knees fully extended, and the ankles relaxed. Ten consecutive measurements were obtained from each measurement site and averaged for analysis.

    Time frame: Baseline, 48 hours after DOMS induction, and immediately after foam rolling

  3. Pain

    Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS) during standardized gastrocnemius stretching. Participants rated their pain intensity on a continuous scale ranging from 0 cm (no pain) to 10 cm (worst imaginable pain). Higher values indicate greater pain intensity.

    Time frame: Baseline, 48 hours after DOMS induction, and immediately after foam rolling

07

Study locations

1 site
  • Hacettepe University
    Ankara, Ankara 06050, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

2 registry updates since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 2 updates
  1. Oct 20, 2026
    Minor edits only
    + 3 other changes: responsible party, design details and secondary outcomes
  2. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07877181
Responsible party
Özgün Uysal (Principal Investigator, Hacettepe University) — Principal investigator
First posted
Oct 16, 2026
Start date
Jan 1, 2023
Primary completion
Jun 1, 2023
Completion
Jun 1, 2023
Last update
Oct 20, 2026

Study contacts

Gulcan Harput
principal investigator · Hacettepe University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion